2013
DOI: 10.1016/j.ydbio.2013.01.035
|View full text |Cite
|
Sign up to set email alerts
|

Making sense of Dlx1 antisense RNA

Abstract: Long non-coding RNAs (lncRNAs) have been recently recognized as a major class of regulators in mammalian systems. LncRNAs function by diverse and heterogeneous mechanisms in gene regulation, and are key contributors to development, neurological disorders, and cancer. This emerging importance of lncRNAs, along with recent reports of a functional lncRNA encoded by the mouse Dlx5-Dlx6 locus, led us to interrogate the biological significance of another distal-less antisense lncRNA, the previously uncharacterized D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
39
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(40 citation statements)
references
References 92 publications
1
39
0
Order By: Relevance
“…5C). 56 This suggests that Dlx1as acts rather as a gene-activating ncRNA than keeping Dlx1 mRNA levels at check. Notably, Dlx1as is associated to both PRC1 and Med12 arguing that transcriptional activation by Mediator-ncRNA complexes is likely inhibited by PRC1.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…5C). 56 This suggests that Dlx1as acts rather as a gene-activating ncRNA than keeping Dlx1 mRNA levels at check. Notably, Dlx1as is associated to both PRC1 and Med12 arguing that transcriptional activation by Mediator-ncRNA complexes is likely inhibited by PRC1.…”
Section: Discussionmentioning
confidence: 99%
“…55 As reported for Hoxd11 mutant mice, 53 ablation of Dlx1as was shown to generate a skeletal phenotype. 56 Therefore, we asked whether Dlx1as had an impact on the transcriptional activation of Hoxd11. To this end we transfected mESCs with either control siRNA or siRNA pools targeting Dlx1as (Fig.…”
Section: Med12 Acts As a Transcriptional Activator Of Key Developmentmentioning
confidence: 99%
“…Recently, a number of hallmark reports have revealed the versatile molecular mechanisms of regulation exerted by lncRNA in human or rodent embryonic stem cell (ESC) models, such as interacting with proteins and regulating their function (Hung et al 2011, Ng et al 2013, regulating the action of chromatin-modifying factors by directing interaction (Klattenhoff et al 2013), inactivating X chromosome by direct binding (Ohhata et al 2011), promoting organelle formation (Chen & Carmichael 2009), inhibiting antisense mRNA expression (Santoro et al 2013), promoting antisense mRNA degradation (Kraus et al 2013), regulating mRNA export from nucleus (Chen & Carmichael 2009), acting as competing endogenous RNAs (ceRNAs) to inhibit the function of miRNA (Cheng & Lin 2013), and acting as a decoy which binds DNA-binding proteins and prevents them from approaching target sites in genomic DNA (Kino et al 2010, Redon et al 2010). Given such a wide variety of regulatory roles, the exact molecular regulations conferred by lncRNAs remain to be elucidated.…”
Section: A Novel Regulatory Layer In Cellular Development: Lncrnasmentioning
confidence: 99%
“…First, as a competitor, lncRNA can bind to DNAbinding proteins, such as transcription factors (Hung 2011, Ng 2013, and inhibit their attachment to target DNA. They can also bind complimentarily to some structures in DNA molecules and hinder protein binding to specific antisense mRNA (Kraus et al 2013), or to miRNAs for post-transcriptional regulation (Zhang et al 2010). Secondly, lncRNA can activate epigenetic modifiers or recruit them to specific target sites, thus enhancing DNA methylation (Berghoff et al 2013) and histone modifications (Yap et al 2010, Klattenhoff et al 2013.…”
Section: A Novel Regulatory Layer In Cellular Development: Lncrnasmentioning
confidence: 99%
“…Indeed, it is emerging that lncRNAs are involved in the pathology of neurological diseases related to imprinting, for instance, Prader-Willi syndrome (PWS) and Angelman syndrome (AS) (Koerner et al, 2009). Additionally, lncRNAs that are Morphologically normal together with mild skull and neurological defects by gene inactivation (Kraus et al, 2013) …”
Section: Lncrnas In Diseases Of the Cns And Brainmentioning
confidence: 99%